Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Liu-Cheng Li, Yong-Yue Han, Zhi-Hui Zhang, Wen-Cheng Zhou, Hong-Mei Fang, Jiao Qu & Lian-Di Kan. (2021) Chronic Obstructive Pulmonary Disease Treatment and Pharmacist-Led Medication Management. Drug Design, Development and Therapy 15, pages 111-124.
Read now
Read now
Gerard Criner & Sean Duffy. (2021) Reducing and managing chronic obstructive pulmonary disease exacerbations with tiotropium + olodaterol. Current Medical Research and Opinion 37:2, pages 275-284.
Read now
Read now
John R Hurst, Kevin Gruffydd-Jones, Mousumi Biswas, Deniz Guranlioglu, Martin Jenkins, Neda Stjepanovic & Arushi Bamrara. (2020) Efficacy and Safety of LAMA/LABA Fixed-Dose Combination Therapies in Chronic Obstructive Pulmonary Disease: A Systematic Review of Direct and Indirect Treatment Comparisons. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1529-1543.
Read now
Read now
Timothy E Albertson, Willis S Bowman, Richart W Harper, Regina M Godbout & Susan Murin. (2019) Evidence-based review of data on the combination inhaler umeclidinium/vilanterol in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1251-1265.
Read now
Read now
Articles from other publishers (29)
Jingjing Lu, Yan Shi, Feng Zhang, Ying Zhang, Xiangwang Zhao, Haiyan Zheng, Lingyu Li, Shiqiao Zhao & Liming Zhao. (2023) Mechanism of lnRNA-ICL involved in lung cancer development in COPD patients through modulating microRNA-19-3p/NKRF/NF-κB axis. Cancer Cell International 23:1.
Crossref
Crossref
Xiufeng Wu, Zhaoliu Cao, Jiang Ni, Xiaoyuan Zheng, Lizhen Zhu, Xin wang, Juan Lv, Shijun Zhou, Yongjuan Ding & Ruirong Wu. (2023) Compatibility and aerosol characteristics of beclomethasone mixed with N-acetylcysteine. Heliyon 9:4, pages e15357.
Crossref
Crossref
Ching-Fu Weng, Chien-Chih Wu, Mei-Hsuan Wu & Fang-Ju Lin. (2023) Comparison of Clinical Outcomes Among Different Fixed-Dose Combinations of Long-Acting Muscarinic Antagonists and Long-Acting β2-Agonists in Patients With COPD. Chest 163:4, pages 799-814.
Crossref
Crossref
Roberto G. Carbone, Giovanni Bottino, Simone Negrini & Francesco Puppo. (2023) Early COPD diagnosis and treatment: A case report. Respiratory Medicine Case Reports 42, pages 101821.
Crossref
Crossref
Marc Miravitlles, Tomotaka Kawayama & Michael Dreher. (2022) LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations. Journal of Clinical Medicine 11:22, pages 6623.
Crossref
Crossref
Afisi S. Ismaila, Katrin Haeussler, Alexandrosz Czira, Vanita Tongbram, Mia Malmenäs, Jatin Agarwal, Maria Nassim, Marija Živković-Gojović, Yunrong Shen, Xinzhe Dong, Maria Duarte, Chris Compton, Claus F. Vogelmeier & David M. G. Halpin. (2022) Comparative Efficacy of Umeclidinium/Vilanterol Versus Other Bronchodilators for the Treatment of Chronic Obstructive Pulmonary Disease: A Network Meta-Analysis. Advances in Therapy 39:11, pages 4961-5010.
Crossref
Crossref
Pengpeng Liang, Yufei Li, Yanan Feng, Guoliang Yin, Suwen Chen, Xiangyi Liu & Fengxia Zhang. (2022) Effects of Acupuncture-Related Therapies in the Rehabilitation of Patients with Post-Stroke Aphasia—A Network Meta-Analysis of Randomized Controlled Trials. Brain Sciences 12:10, pages 1282.
Crossref
Crossref
Bruno Sposato, Elisa Petrucci, Andrea Serafini, Fabio Lena, Leonardo Gianluca Lacerenza, Andrea Montagnani, Massimo Alessandri, Alberto Cresti, Raffaele Scala, Paola Rogliani, Alberto Ricci, Antonio Perrella & Marco Scalese. (2021) Which LABA/LAMA should be chosen in COPD patients in real life?. Pulmonary Pharmacology & Therapeutics 71, pages 102076.
Crossref
Crossref
Martine Hoogendoorn, Isaac Corro Ramos, Stéphane Soulard, Jennifer Cook, Erkki Soini, Emma Paulsson & Maureen Rutten-van Mölken. (2021) Cost-effectiveness of the fixed-dose combination tiotropium/olodaterol versus tiotropium monotherapy or a fixed-dose combination of long-acting β2-agonist/inhaled corticosteroid for COPD in Finland, Sweden and the Netherlands: a model-based study. BMJ Open 11:8, pages e049675.
Crossref
Crossref
Dave Singh, James F. Donohue, Isabelle H. Boucot, Neil C. Barnes, Chris Compton & Fernando J. Martinez. (2021)
Future concepts in bronchodilation for COPD: dual-
versus
monotherapy
. European Respiratory Review 30:160, pages 210023.
Crossref
Crossref
Yu-Luan Chen, Weimin Wang, Lei Shi & John Eddy. (2021) An ultrasensitive LC–MS/MS method and application to clinical dose-range finding for glycopyrrolate via an e-Nebulizer. Bioanalysis 13:12, pages 959-968.
Crossref
Crossref
Arnaud Bourdin, Nicolas Molinari, Gary T. Ferguson, Barinder Singh, Mohd Kashif Siddiqui, Ulf Holmgren, Mario Ouwens, Martin Jenkins & Enrico De Nigris. (2021) Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol Fumarate versus Other Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis. Advances in Therapy 38:6, pages 3089-3112.
Crossref
Crossref
M. Zysman, B. Ribeiro Baptista, T. Soumagne, V. Marques da Silva, C. Martin, C. Thibault de Menonville, L. Boyer, B. Degano, C. Morelot Panzini, P.R. Burgel, T. Perez, A. Bourdin, C. Raherison, H. Pégliasco, D. Piperno, C. Zanetti, H. Morel, B. Delclaux, C. Delafosse, A. Lorenzo, B. Housset, F. Chabot, P. Devillier, G. Deslée & N. Roche. (2021) Optimisation du traitement médicamenteux des patients atteints de BPCO en état stable. Position de la Société de pneumologie de langue française. Actualisation 2021. Revue des Maladies Respiratoires 38:5, pages 539-561.
Crossref
Crossref
Hong Chen, Ke Wang, Tao Yuan, Xiaoming Wang, Lan Huanng, Zhenhuan Jiang, Keyang Chen & Yuejun Du. (2021) Dual bronchodilator versus inhaled corticosteroid/long-acting β2-agonist in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized controlled trials. International Immunopharmacology 93, pages 107447.
Crossref
Crossref
Hyun Woo Lee, Jimyung Park, Eun Jin Jang & Chang-Hoon Lee. (2020) Comparisons of exacerbations and mortality among LAMA/LABA combinations in stable chronic obstructive pulmonary disease: systematic review and Bayesian network meta-analysis. Respiratory Research 21:1.
Crossref
Crossref
Eleanor L Axson, Adam Lewis, James Potts, Marie Pang, Scott Dickinson, Helene Vioix & Jennifer K Quint. (2020) Inhaled therapies for chronic obstructive pulmonary disease: a systematic review and meta-analysis. BMJ Open 10:9, pages e036455.
Crossref
Crossref
Yiting Chen, Shilin Du, Zhirui Zhang, Wenxiu He, Enhao Lu, Rui Wang, Xianyi Sha & Yan Ma. (2020) Compatible Stability and Aerosol Characteristics of Atrovent® (Ipratropium Bromide) Mixed with Salbutamol Sulfate, Terbutaline Sulfate, Budesonide, and Acetylcysteine. Pharmaceutics 12:8, pages 776.
Crossref
Crossref
Luigino Calzetta, Fabiano Di Marco, Francesco Blasi, Mario Cazzola, Stefano Centanni, Claudio Micheletto, Andrea Rossi & Paola Rogliani. (2019) Impact of ICS/LABA and LABA/LAMA FDCs on functional and clinical outcomes in COPD: A network meta-analysis. Pulmonary Pharmacology & Therapeutics 59, pages 101855.
Crossref
Crossref
Hyun Woo Lee, Jimyung Park, Junwoo Jo, Eun Jin Jang & Chang-Hoon Lee. (2019) Comparisons of exacerbations and mortality among regular inhaled therapies for patients with stable chronic obstructive pulmonary disease: Systematic review and Bayesian network meta-analysis. PLOS Medicine 16:11, pages e1002958.
Crossref
Crossref
Tsai-Hui Lin, Shu-I Chen, Yuan-Chih Su, Mei-Chen Lin, Hung-Jen Lin & Sheng-Teng Huang. (2019) Conventional Western Treatment Combined With Chinese Herbal Medicine Alleviates the Progressive Risk of Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study. Frontiers in Pharmacology 10.
Crossref
Crossref
Pierachille Santus, Matteo Pecchiari, Francesco Tursi, Vincenzo Valenti, Marina Saad & Dejan Radovanovic. (2019) The Airways’ Mechanical Stress in Lung Disease: Implications for COPD Pathophysiology and Treatment Evaluation. Canadian Respiratory Journal 2019, pages 1-8.
Crossref
Crossref
Zaina T. Al-Salama & James E. Frampton. (2019) Glycopyrronium/Formoterol: A Review in COPD. Drugs 79:13, pages 1455-1466.
Crossref
Crossref
Xiaoyao Ma, Aina Liu, Wenjuan Liu, Zhihua Wang, Nianwei Chang, Suyun Li, Jiansheng Li, Yuanyuan Hou & Gang Bai. (2019) Analyze and Identify Peiminine Target EGFR Improve Lung Function and Alleviate Pulmonary Fibrosis to Prevent Exacerbation of Chronic Obstructive Pulmonary Disease by Phosphoproteomics Analysis. Frontiers in Pharmacology 10.
Crossref
Crossref
Mateo Zuluaga Gómez, Daniel Vanegas Isaza & Jorge Hernando Donado Gómez. (2019) Aproximación a los metanálisis de comparación de múltiples tratamientos: una revisión de la literatura. Medicina UPB 38:2, pages 158-167.
Crossref
Crossref
Mohd Kashif Siddiqui, Pragya Shukla, Martin Jenkins, Mario Ouwens, Deniz Guranlioglu, Patrick Darken & Mousumi Biswas. (2019)
Systematic review and network meta-analysis of the efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler in comparison with other long-acting muscarinic antagonist/long-acting β
2
-agonist fixed-dose combinations in COPD
. Therapeutic Advances in Respiratory Disease 13, pages 175346661989450.
Crossref
Crossref
Matyas Szigeti, Levente Kovacs & Tamas Ferenci. (2019) Stability of relative and absolute metrics: empirical evidence from pulmonology. Stability of relative and absolute metrics: empirical evidence from pulmonology.
Eneida M. Harrison & Victor Kim. (2019) Long-acting maintenance pharmacotherapy in chronic obstructive pulmonary disease. Respiratory Medicine: X 1, pages 100009.
Crossref
Crossref
Dinesh Yogaratnam, Mary Bylo, Katherine M. Carey, Valerie Coppenrath, Aimee Dawson, Amy B.W. LaMothe, Ann M. Lynch & Nnamdi Okeke. 2019. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions
171
182
.
Toshio Nakaki. 2019. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions
151
161
.